Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$1.64B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$1.1B |
| 3 |
Apple
AAPL
|
+$928M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$804M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$765M |
Top Sells
| 1 |
CRH
CRH
|
+$771M |
| 2 |
Bank of America
BAC
|
+$711M |
| 3 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$536M |
| 4 |
NVIDIA
NVDA
|
+$481M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$417M |
Sector Composition
| 1 | Technology | 29.49% |
| 2 | Financials | 11.51% |
| 3 | Consumer Discretionary | 10.99% |
| 4 | Healthcare | 10.02% |
| 5 | Communication Services | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Mersana Therapeutics
MRSN
$35.6M
| $352K | ﹤0.01% |
6,083
+4,717
| +345% | +$273K |
|
3102
Arcutis Biotherapeutics
ARQT
$2.07B
| $351K | ﹤0.01% |
108,660
-98,417
| -48% | -$318K |
|
3103
Celcuity
CELC
$2.33B
| $350K | ﹤0.01% |
24,021
+20,830
| +653% | +$304K |
|
3104
Neumora Therapeutics
NMRA
$262M
| $350K | ﹤0.01% |
+20,539
| New | +$350K |
|
3105
Invesco Solar ETF
TAN
$726M
| $350K | ﹤0.01% |
6,550
-14,790
| -69% | -$790K |
|
|
JBIO
3106
Jade Biosciences, Inc. Common Stock
JBIO
$251M
| $348K | ﹤0.01% |
440
+330
| +300% | +$261K |
|
3107
Oak Valley Bancorp
OVLY
$244M
| $348K | ﹤0.01% |
11,623
+7,946
| +216% | +$238K |
|
3108
Gambling.com
GAMB
$288M
| $347K | ﹤0.01% |
35,473
+16,113
| +83% | +$158K |
|
3109
Intrepid Potash
IPI
$389M
| $347K | ﹤0.01% |
14,523
-123
| -0.8% | -$2.94K |
|
|
NOAH
3110
Noah Holdings
NOAH
$781M
| $347K | ﹤0.01% |
25,136
-1,400
| -5% | -$19.3K |
|
3111
SES AI
SES
$457M
| $347K | ﹤0.01% |
189,541
+151,171
| +394% | +$277K |
|
3112
ATAI Life Sciences
ATAI
$992M
| $346K | ﹤0.01% |
245,717
-22,923
| -9% | -$32.3K |
|
3113
Monte Rosa Therapeutics
GLUE
$297M
| $346K | ﹤0.01% |
61,268
+48,097
| +365% | +$272K |
|
3114
KRONOS Worldwide
KRO
$694M
| $345K | ﹤0.01% |
34,705
+26,460
| +321% | +$263K |
|
3115
Aris Water Solutions
ARIS
$787M
| $344K | ﹤0.01% |
41,006
+35,457
| +639% | +$297K |
|
3116
Y-mAbs Therapeutics
YMAB
$390M
| $344K | ﹤0.01% |
50,437
+44,135
| +700% | +$301K |
|
|
ORLA
3117
Orla Mining
ORLA
$3.77B
| $342K | ﹤0.01% |
104,964
-1,799
| -2% | -$5.86K |
|
3118
Quantum-Si Incorporated
QSI
$239M
| $342K | ﹤0.01% |
169,608
+121,670
| +254% | +$245K |
|
3119
Destination XL Group
DXLG
$80.3M
| $340K | ﹤0.01% |
+77,264
| New | +$340K |
|
3120
NI Holdings
NODK
$276M
| $340K | ﹤0.01% |
26,191
+11,987
| +84% | +$156K |
|
3121
iShares MSCI Saudi Arabia ETF
KSA
$558M
| $339K | ﹤0.01% |
8,000
| – | – |
|
3122
Mistras Group
MG
$299M
| $339K | ﹤0.01% |
46,164
+24,516
| +113% | +$180K |
|
|
URG
3123
Ur-Energy
URG
$533M
| $339K | ﹤0.01% |
219,929
+198,147
| +910% | +$305K |
|
3124
Aura Biosciences
AURA
$384M
| $338K | ﹤0.01% |
38,169
+33,295
| +683% | +$295K |
|
3125
908 Devices
MASS
$202M
| $338K | ﹤0.01% |
30,113
+26,271
| +684% | +$295K |
|